- Please note: You will need to create an account unless you have used PACE for previous CE events. You will not automatically have an account under your email address.
- LIVE CONFERENCE CE: Click here to fill out the evaluation and download your CE certificate from the live conference. CE for the live conference will be available until June 1, 2025.
- RECORDED CONFERENCE CE: Click here to fill out the evaluation and download your CE certificate from the recorded conference. CE For the recorded conference will be available until October 1,2025
- To calculate your credits, please click here.
- March 28 – 30, 2025 – San Francisco, CA
- Jointly provided by Partners for Advancing Clinical Education (PACE) and the American Sexual health Association
- Computer system hardware/software requirements: Access to internet and browser. For specific information on accessing the recordings, please click here.
Target Audience
This activity is intended for physicians, registered nurses, physician’s associate, physician assistant, nurse practitioner, other APRN.
Educational Objectives
Upon completion of this activity, participants should be able to::
| OBJECTIVE 1 Describe how to access and clinically apply the US Medical Eligibility for Contraceptive Use guideline and the Selected Practice Recommendation guideline and how to use the mobile app. |
| OBJECTIVE 2 Demonstrate patient centered language for describing an intervention to a patient. |
| OBJECTIVE 3 Discuss 2 management options for clients who experience anxiety and pain with placement of contraceptive devices |
| OBJECTIVE 4 List 2 advantages and 2 disadvantages of contraceptive methods that were FDA approved recently as compared to older contraceptive methods. |
Faculty
| Aletha | Akers |
| Alina | Salganicoff |
| Aisha | Mays |
| Alyson | Decker |
| Allison | Edelman |
| Anita | Nelson |
| Becca | Neuwirth |
| Bennett | Lareau |
| Eleanor | Schwarz |
| Carrie | Cwiak |
| Debbie | Barish |
| Diana | Greene Foster |
| Dominika | Seidman |
| George | Sawaya |
| Ina | Park |
| Jenn | Karlin |
| Joely | Pritzker |
| Joshua | O’Neal |
| Kelly | Johnson |
| Lauren | Ralph |
| Lori | Freedman |
| Meghan | Whitfied |
| Melanie | Deal |
| Melissa Carol | Matulich |
| Mike | Policar |
| Mitchell | Creinin, MD |
| Nick | Van Wagoner |
| Nicole Irene | Economou |
| Olivia | Campa |
| Rosalyn | Plotzker |
| Sarah | Nathan |
| Patty | Cason |
| Wyatt | Hanft |
Program Agenda
Click here for a copy of the agenda.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Lauren Maggart prior to the live event at conference@ashasexualhealth.org.
Fee Information
This activity requires registration to the 2025 Contraceptive Technology Conference. Click here for registration information.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education and the American Sexual Health Association (ASHA). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this live activity for a maximum of 49.25 AMA PRA Category 1 Credit(s)™. Partners designates this enduring material for a maximum of 49.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 49.25 contact hours.
Designated for 6.0 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Instructions for Enduring Credit
Participation in this self-study activity should be completed in approximately 49.25 hour(s). To successfully complete this activity and receive CE credit, learners must follow these steps during the period from April 22, 2025 through October 1,2025:
- Review the objectives and disclosures
- Study the educational content
- Visit https://cme.partnersed.com/ctc25E
- Complete the activity evaluation.